![Maya Martinez-Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maya Martinez-Davis
Direktor/Vorstandsmitglied bei
PERSPECTIVE THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Maya Martinez-Davis is currently an Independent Director at Perspective Therapeutics, Inc. since 2025 and President-US Pharmaceuticals at GSK Plc since 2020.
Former roles include Independent Director at Mirati Therapeutics, Inc. from 2018 to 2024 and President-Biopharma Latin America at Merck KGaA from 2016 to 2019.
Education includes undergraduate studies at St. Louis University and graduate studies at Instituto de Empresa SL.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Maya Martinez-Davis
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.01.2020 |
| PERSPECTIVE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 03.09.2025 |
Ehemalige bekannte Positionen von Maya Martinez-Davis
| Unternehmen | Position | Ende |
|---|---|---|
| MIRATI THERAPEUTICS | Direktor/Vorstandsmitglied | 23.01.2024 |
| MERCK KGAA | Corporate Officer/Principal | 01.08.2019 |
Ausbildung von Maya Martinez-Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
 Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
